First patient included in new clinical investigation on pressure ulcers
RLS Global’s new clinical investigation with ChloraSolv for the treatment of pressure ulcers includes six clinics in Sweden, Finland and the UK. The first patient was enrolled on September 1 at a clinic in the UK.The investigation has been approved by authorities in all three countries.Pressure ulcers belong to the group of hard-to-heal wounds and cause much suffering and high costs worldwide. Studies show that pressure ulcers affect as many as over 10 (6–27) percent of all hospitalised patients in Europe (ref). Previous investigations have shown that ChloraSolv is effective and safe in